Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]          
Cash, Uninsured Amount $ 32,248,337   $ 32,248,337   $ 11,608,582
Inventory, Net 806,407   806,407   $ 577,690
Research and Development Expense $ 4,910,827 $ 1,643,659 $ 15,555,725 $ 4,950,457  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 3,509,956   3,509,956   3,980,804
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in Shares)     2,627,631   2,874,017
Amortization $ 4,752 $ 4,751 $ 14,254 $ 10,824  
Equity Method Investment, Ownership Percentage 69.40%   69.40%    
ViralClear [Member]          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]          
Noncontrolling Interest, Ownership Percentage by Parent 30.60%   30.60%    
Patents [Member]          
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]          
Finite-Lived Intangible Asset, Useful Life     20 years